STOCK TITAN

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Xtant Medical (NYSE American: XTNT) will release fourth-quarter and full-year 2025 financial results before trading on Tuesday, March 31, 2026.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
earnings date

Xtant Medical (NYSE American: XTNT) will release fourth-quarter and full-year 2025 financial results before trading on Tuesday, March 31, 2026. A conference call with CEO Sean Browne and CFO Scott Neils is scheduled for 8:30 AM ET that day.

Investors can join by dial-in or webcast; a replay will be posted under "Investor info" on the company's website after the live call.

Loading...
Loading translation...
Argus Mar 25 session
+0.55% close to close Open Argus
Details

News Market Reaction – XTNT

On Mar 25, the day this news came out, XTNT closed 0.55% above the previous close.

Data tracked by StockTitan Argus for the Mar 25 session.

Key Figures

Earnings release date: March 31, 2026 Fiscal year-end: December 31, 2025 Conference time: 8:30 AM ET +1 more
Earnings release date
March 31, 2026
Q4 and full year 2025 results release before market open
Fiscal year-end
December 31, 2025
End date for fourth quarter and full year being reported
Conference time
8:30 AM ET
Scheduled time for Q4 2025 earnings conference call
Conference passcode
581090
Dial-in passcode for Q4 2025 earnings conference call

Historical Context

5 past events · Latest: Mar 02
5 events
  1. Mar 02

    Divestiture proceeds update

    24h Move
    +0.2%

    Final Companion Spine payment lifted total Coflex and Paradigm divestiture proceeds.

  2. Feb 25

    Conference participation

    24h Move
    +0.8%

    Management participation in Canaccord musculoskeletal conference and investor meetings.

  3. Dec 11

    Product launch

    24h Move
    -1.1%

    Commercial launch of next‑generation nanOss Strata synthetic bone graft.

  4. Dec 01

    Business sale completion

    24h Move
    +1.8%

    Companion Spine completed acquisition of Paradigm Spine assets from Xtant.

  5. Dec 01

    Asset divestiture

    24h Move
    +1.8%

    Xtant completed sale of non-core Coflex assets and Paradigm OUS entities.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BELGRADE, Mont., March 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before the start of trading on Tuesday, March 31, 2026. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET on that day.

Conference Details:

Conference Date: Tuesday, March 31, 2026
Conference Time: 8:30 AM ET
Conference Dial-in: 888-506-0062
International Dial-in: 973-528-0011
Passcode: 581090
Conference Call Name: Xtant Medical Q4 2025 Financial Results
Webcast link: https://www.webcaster5.com/Webcast/Page/3039/53616

Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-31-2026-302724338.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Xtant Medical (XTNT) release Q4 and full-year 2025 results?

Xtant Medical will release Q4 and full-year 2025 results before trading on March 31, 2026. According to the company, the report covers the period ended December 31, 2025, and precedes an 8:30 AM ET conference call that same day.

What time is the Xtant Medical (XTNT) earnings conference call on March 31, 2026?

The Xtant Medical conference call is scheduled for 8:30 AM ET on March 31, 2026. According to the company, CEO Sean Browne and CFO Scott Neils will host the live call and discuss fourth-quarter and full-year 2025 results.

How can investors join the Xtant Medical (XTNT) March 31, 2026 conference call?

Investors can join by dialing 888-506-0062 or using the international line 973-528-0011 with passcode 581090. According to the company, a webcast link is also provided for live listening and participation.

Who will host Xtant Medical's (XTNT) March 31, 2026 earnings call?

CEO Sean Browne and CFO Scott Neils will host the March 31, 2026 earnings call. According to the company, they will present fourth-quarter and full-year 2025 financial results and answer investor questions during the live session.

Where will the replay of Xtant Medical's (XTNT) March 31, 2026 call be available?

A replay will be available on Xtant Medical's website under the "Investor info" section after the live call. According to the company, the replay will follow the live webcast for on-demand investor access.

Keep reading